Contact Us: 01282 426380
KM Financial Solutions | UK biotech signs $1bn deal to develop liver disease drugs
119938
post-template-default,single,single-post,postid-119938,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

UK biotech signs $1bn deal to develop liver disease drugs

21 Apr UK biotech signs $1bn deal to develop liver disease drugs

Posted at 04:00h in News by
0 Likes
Ochre Bio partnering with Germany’s Boehringer Ingelheim on treatments that will harness the organ’s capacity to regenerate
No Comments

Sorry, the comment form is closed at this time.